{
  "trial_id": "NCT04822675",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "severe ischemic Mitral regurgitation (MR)",
      "label": "met",
      "evidence": "2017 American Society of Echocardiography (ASE) guidelines for noninvasive evaluation of native valvular regurgitation"
    },
    {
      "criterion": "Presence of reversible myocardial ischemia confirmed by preoperative myocardial viability study using radionuclide imaging.",
      "label": "met",
      "evidence": "radionuclide imaging"
    }
  ],
  "exclusion": [
    {
      "criterion": "mixed mitral valve pathology, including fibroelastic deficiency, rheumatic valve disease, ruptured mitral valve chordae, mitral valve endocarditis",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "acute ischemic MR, defined as MR caused by papillary muscle infarction and rupture",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age < 18 years.",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has Marfan's syndrome with severe mitral valve prolapse and regurgitation, planned for MV repair but lost to follow-up. Now prepared for surgery.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT04822675",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}